Search Results
Test Catalog
FIL2M - Overview: Interleukin 2
Interleukin 2
IGF-2
FHEP2 - Overview: Heparin Cofactor II
Assessment of thrombotic risk associated with heparin cofactor II levels.
FIA2A - Overview: IA-2 Antibody
IA-2 Antibody
Second-tier testing of newborns with an abnormal primary screening result for mucopolysaccharidosis type II (MPS II, decreased iduronate-2-sulfatase) Follow-up testing for evaluation of an abnormal newborn screening result for MPS II This...
Identification of herpes simplex virus I and II infection
Diagnosis of COVID-19 illness due to SARS-CoV-2
Second-tier testing of newborns with an abnormal primary screening result for mucopolysaccharidosis type II (MPS II, decreased iduronate-2-sulfatase) where quantitation of the glycosaminoglycans dermatan and heparan sulfate is desired in...
I2SB - Overview: Iduronate-2-Sulfatase, Blood Spot
Supporting the biochemical diagnosis of mucopolysaccharidosis II (MPS II; Hunter syndrome) This test is not useful for determining carrier status for MPS II.
FFMI2 - Overview: Anti-Mi-2 Ab
Anti-Mi-2 Ab
FGFP2 - Overview: IgG4 Food Panel II
IgG4 Food Panel II
I2SWB - Overview: Iduronate-2-Sulfatase, Leukocytes
Supporting the biochemical diagnosis of mucopolysaccharidosis II (MPS II; Hunter syndrome) in whole blood specimens This test is not useful for carrier detection for MPS II.
FFTYC - Overview: Collagen Type II antibody
Collagen Type II antibody
FFPII - Overview: Food Panel II IgG
Food Panel II IgG
Aiding in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection
Confirmatory detection of human T-cell lymphotropic virus types I and II (HTLV-I and HTLV-II)-specific IgG antibodies in human serum specimens that are consistently reactive by initial screening tests Differentiating between HTLV-I- and...
Aiding in the identification of individuals with an adaptive immune response to SARS-CoV-2, indicating prior infection or vaccination
FABP2 - Overview: Allergic Bronchopulmonary Aspergillosis Panel II
Allergic Bronchopulmonary Aspergillosis Panel II
FPF12 - Overview: Prothrombin Fragment 1+2 MoAb
Prothrombin Fragment 1+2 MoAb
F2_IS - Overview: Factor II Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor II
ZW2 - Overview: Miscellaneous MML Referral Test 2
Miscellaneous MML Referral Test 2
A2PI - Overview: Alpha-2 Plasmin Inhibitor, Plasma
Diagnosing congenital alpha-2 plasmin inhibitor deficiencies (rare) Providing a complete assessment of disseminated intravascular coagulation, intravascular coagulation and fibrinolysis, or hyperfibrinolysis (primary fibrinolysis), when...
2INHE - Overview: Factor II Inhibitor Evaluation, Plasma
Detection and quantitation of inhibitor to factor II This test is not useful for the detection of a lupus-like circulating anticoagulant inhibitor, a nonspecific circulating anticoagulant, or other inhibitors that are not specific for...
Confirmatory detection of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2)-specific IgG antibodies in spinal fluid specimens that are consistently reactive by initial screening tests Differentiating between HTLV-1- and...
HIS12 - Overview: HIV-1/HIV-2 RNA Detection, Serum
Diagnosis of HIV-1 and/or HIV-2 infection in individuals with indeterminate or inconclusive HIV serologic test results Diagnosis of HIV-1 and/or HIV-2 infection in individuals with acute or early HIV-1 and/or HIV-2 infection Diagnosis...
HIP12 - Overview: HIV-1/HIV-2 RNA Detection, Plasma
Diagnosis of HIV-1 and/or HIV-2 infection in individuals with indeterminate or inconclusive HIV serologic test results Diagnosis of HIV-1 and/or HIV-2 infection in individuals with acute or early HIV-1 and/or HIV-2 infection Diagnosis of...
HPP12 - Overview: HIV-1/HIV-2 RNA Detection Prenatal, Plasma
Diagnosis of HIV-1 and/or HIV-2 infection in pregnant individuals with indeterminate or inconclusive HIV serologic test results Diagnosis of HIV-1 and/or HIV-2 infection in pregnant individuals in the acute or early phase of HIV-1 and/or...
HPS12 - Overview: HIV-1/HIV-2 RNA Detection Prenatal, Serum
Diagnosis of HIV-1 and/or HIV-2 infection in pregnant individuals with indeterminate or inconclusive HIV serologic test results Diagnosis of HIV-1 and/or HIV-2 infection in pregnant individuals in the acute or early phase of HIV-1 and/or...
2OHGP - Overview: 2-Hydroxyglutaric Aciduria Gene Panel, Varies
Follow up for abnormal biochemical results suggestive of 2-hydroxyglutaric aciduria Establishing a molecular diagnosis for patients with 2-hydroxyglutaric aciduria Identifying variants within genes known to be associated with...
Qualitative screening detection of human T-cell lymphotropic virus types 1 and 2 (HTLV-1/-2) specific antibodies with confirmation and differentiation between HTLV-1 and HTLV-2 infection This test should not be used as a screening or...
SIL2R - Overview: Interleukin-2 Receptor Alpha Soluble, Plasma
Measuring the concentration of soluble interleukin-2 receptor alpha (sIL-2r alpha) in plasma Aids in the diagnosis and evaluation of patients for lymphoproliferative disorders, including autoimmune lymphoproliferative syndrome,...
F_2 - Overview: Coagulation Factor II Activity Assay, Plasma
Diagnosing a congenital deficiency (rare) of coagulation factor II Evaluating acquired deficiencies associated with liver disease or vitamin K deficiency, oral anticoagulant therapy, and antibody-induced deficiencies (eg, in association...
NAT2Q - Overview: N-Acetyltransferase 2 (NAT2) Genotype, Varies
Identifying patients who may be at risk for altered metabolism of drugs that are substrates of arylamine N-acetyltransferase type 2, including isoniazid
2INHT - Overview: Factor II Inhibitor Profile, Technical Interpretation
Technical interpretation of inhibitor to factor II testing This test is not useful for the detection of a lupus-like circulating anticoagulant inhibitor, a nonspecific circulating anticoagulant, or other inhibitors that are not specific...
2AINH - Overview: Factor II Inhibitor Profile, Professional Interpretation
Interpretation of testing for the detection and quantitation of inhibitor to factor II
LEV2P - Overview: Level 2 Gross and microscopic (Bill Only)
Level 2 Gross and microscopic (Bill Only)
EXT2 - Overview: Exostosin 2 (EXT2) Immunostain, Technical Component Only
Identification of exostosin 2 associated membranous nephropathy
HIVSS - Overview: HIV-1 and HIV-2 Antigen and Antibody Routine Screen, Serum
Screening for HIV-1 and HIV-2 infection in nonsymptomatic, nonpregnant individuals older than 2 years This test should not be used as a screening or confirmatory test for blood donor specimens.
HVCOP - Overview: HIV-1 and HIV-2 Antigen and Antibody Routine Screen, Plasma
Screening for HIV-1 and HIV-2 infection in nonsymptomatic, nonpregnant individuals older than 2 years This test should not be used as a screening or confirmatory test for blood donor specimens.
FHTL - Overview: HTLV I/II DNA, Qualitative Real-Time PCR
HTLV I/II DNA, Qualitative Real-Time PCR
FHV2Q - Overview: HIV-2 DNA/RNA Qualitative Real-Time PCR
HIV-2 DNA/RNA Qualitative Real-Time PCR
2HGA - Overview: 2-Hydroxyglutaric Acid Chiral Analysis, Quantitative, Random, Urine
Determining type of 2-hydroxyglutaric aciduria by chiral analysis of urine
GB2GP - Overview: Beta-2 Glycoprotein 1 Antibodies, IgG, Serum
Evaluating patients with suspected antiphospholipid syndrome by identification of beta-2 glycoprotein 1 IgG antibodies First-line test when antiphospholipid syndrome is strongly suspected, in conjunction with cardiolipin antibodies (IgG...
MB2GP - Overview: Beta-2 Glycoprotein 1 Antibodies, IgM, Serum
Evaluating patients with suspected antiphospholipid syndrome by identification of beta-2 glycoprotein 1 IgM antibodies First-line test when antiphospholipid syndrome is strongly suspected in conjunction with cardiolipin antibodies (IgG...
AB2GP - Overview: Beta-2 Glycoprotein 1 Antibodies, IgA, Serum
Evaluating patients with suspected antiphospholipid syndrome by identification of beta-2 glycoprotein 1 IgA antibodies Evaluating patients at-risk for antiphospholipid syndrome (APS) who are negative for criteria APS tests Estimating the...
GA2P - Overview: Glutaric Aciduria Type II Gene Panel, Varies
Follow up for abnormal biochemical results suggestive of glutaric acidemia type II Establishing a molecular diagnosis for patients with glutaric acidemia type II Identifying variants within genes known to be associated with glutaric...
NCLW - Overview: Neuronal Ceroid Lipofuscinosis, Two-Enzyme Panel, Leukocytes
Supporting the biochemical diagnosis of two neuronal ceroid lipofuscinoses, CLN1 and CLN2 in whole blood specimens This test is not useful for carrier detection.
Qualitative detection of human T-cell lymphotropic virus types I and II (HTLV-I and HTLV-II)-specific antibodies with confirmation and differentiation between HTLV-I and HTLV-II infection This test should not be used to screen blood, human...
Simultaneous detection and differentiation of SARS-CoV-2 (cause of COVID-19), influenza A virus, and influenza B virus in upper or lower respiratory tract specimens from individuals with flu-like illnesses
B2GMG - Overview: Beta-2 Glycoprotein 1 Antibodies, IgG and IgM, Serum
Evaluating patients with suspected antiphospholipid syndrome by identification of beta-2 glycoprotein 1 IgM and IgG antibodies First-line test when antiphospholipid syndrome is strongly suspected in conjunction with cardiolipin antibodies...
Site Search
Beyond Q-tips: The swabbing guide for SARS-CoV-2 - Insights
Webinar" will discuss the various types of swabs that can be used to collect specimens for SARS-CoV-2 molecular testing....
Cases with Dr. Keeney: Case #2 - Insights
detailing the ancillary studies and discussing the differential diagnosis of the cases. View case #2....
Other Archives - Page 2 of 2 - Insights
Skip to Content MayoACCESS MayoLINK...
Week in Review Archives - Page 2 of 2 - Insights
Skip to Content MayoACCESS MayoLINK...
Laboratory/Patient Safety/Quality Archives - Page 2 of 2 - Insights
Skip to Content MayoACCESS MayoLINK...